IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

venBio Partners L.P.

Q4 2018 Holdings

Filed 2019-02-14 | 3 holdings | $38.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Apellis Pharmaceuticals, IncCOM037530106$23.6K1,790,10262.0%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$8.4K875,00022.2%
Menlo Therapeutics Inc.COM586858102$6.0K1,461,55215.8%